Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Joanna,Drozd-Sokołowska ^[1] ; Ewa,Karakulska-Prystupiuk ^[1] ; Przemysław,Biecek ^[2] ; Katarzyna,Kobylińska ^[2] ; Agnieszka,Piekarska ^[3] ; Magdalena,Dutka ^[3] ; Anna,Waszczuk-Gajda ^[1] ; Krzysztof,Mądry ^[1] ; Anna,Kopińska ^[4] ; Aleksandra,Gołos ^[5] ; Joanna,Góra-Tybor ^[6] ; Paweł,Szwedyk ^[7] ; Łukasz,Bołkun ^[8] ; Anna,Czyż ^[9] ; Sebastian,Giebel ^[10] ; Grzegorz Władysław,Basak ^[1] ; Jadwiga,Dwilewicz-Trojaczek ^[1]

作者单位： Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. ^[1] Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland. ^[2] Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland. ^[3] Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland. ^[4] Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland. ^[5] Department of Hematology, Medical University of Lodz, Lodz, Poland. ^[6] Department of Hematology, Ludwik Rydygier Hospital, Cracow, Poland. ^[7] Department of Hematology, Medical University of Bialystok, Bialystok, Poland. ^[8] Department of Hematology, Wroclaw Medical University, Wroclaw, Poland. ^[9] Maria Sklodowska-Curie Institute-Cancer Center, Gliwice Branch, Gliwice, Poland. ^[10]

关键词 acute myeloid leukemia azacitidine bone marrow transplantation myelodysplastic syndromes transplantation